tirzepatide sleep apnea fda approval Approves Zepbound for Patients With Obesity First FDA Approved Sleep Apnea

Right now, 85 to 90 percent of the people I work with as a dietitian are either starting a GLP-1 or plateauing on one

Weight loss may begin within 2-3 weeks

Switching From Contrave to Wegovy: Protocol Your healthcare provider will typically start you on the lowest Wegovy dose (0.25 mg) and follow the standard titration schedule regardless of your prior Contrave dose

(AP Photo/David J

Josephs was prescribed the GLP-1 agonist after getting a high score on an A1C test, which measures blood sugar and is used to help diagnose prediabetes and diabetes

Their use has exploded in recent years, thanks to the introduction of semaglutide, marketed under the brand names Ozempic, which was originally approved in 2017 to treat type 2 diabetes, and Wegovy, approved in 2021 initially for obesity